Europe Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE CLINICAL TRIAL IMAGING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 EUROPE CLINICAL TRIAL IMAGING MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 EUROPE CLINICAL TRIAL IMAGING MARKET: DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.10 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING R&D EXPENDITURE

3.1.2 INCREASING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.3 INCREASING PREVALENCE OF CHRONIC DISEASES

3.1.4 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

3.2 RESTRAINTS

3.2.1 HIGH RISK RADIATION CAUSING DISEASES

3.2.2 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES FOR BUSINESS EXPANSION

3.3.2 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

3.3.3 EMERGING ECONOMIES

3.4 CHALLENGES

3.4.1 STRICT REGULATORY POLICIES

3.4.2 COST OF CLINICAL TRIALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 SERVICES

6.2.1 OPERATIONAL IMAGING SERVICES

6.2.2 READ ANALYSIS SERVICES

6.2.3 TRIAL DESIGN CONSULTING SERVICES

6.2.4 SYSTEM AND TECHNICAL SUPPORT SERVICES

6.3 SOFTWARE

7 EUROPE CLINICAL TRIAL IMAGING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 ONCOLOGY

7.2.1 ECHOCARDIOGRAPHY

7.2.2 MAGNETIC RESONANCE IMAGING

7.2.3 COMPUTED TOMOGRAPHY

7.2.4 POSITRON EMISSION TOMOGRAPHY

7.2.5 NUCLEAR MEDICINE

7.2.6 X-RAY

7.2.7 ULTRASOUND

7.2.8 OPTICAL COHERENCE TOMOGRAPHY

7.2.9 OTHERS

7.3 NEUROLOGY

7.3.1 COMPUTED TOMOGRAPHY

7.3.2 MAGNETIC RESONANCE IMAGING

7.3.3 POSITRON EMISSION TOMOGRAPHY

7.3.4 NUCLEAR MEDICINE

7.3.5 X-RAY

7.3.6 ULTRASOUND

7.3.7 OPTICAL COHERENCE TOMOGRAPHY

7.3.8 OTHERS

7.4 ENDOCRINOLOGY

7.4.1 COMPUTED TOMOGRAPHY

7.4.2 MAGNETIC RESONANCE IMAGING

7.4.3 POSITRON EMISSION TOMOGRAPHY

7.4.4 NUCLEAR MEDICINE

7.4.5 X-RAY

7.4.6 ULTRASOUND

7.4.7 OPTICAL COHERENCE TOMOGRAPHY

7.4.8 OTHERS

7.5 CARDIOLOGY

7.5.1 X-RAY

7.5.2 ULTRASOUND

7.5.3 COMPUTED TOMOGRAPHY

7.5.4 MAGNETIC RESONANCE IMAGING

7.5.5 NUCLEAR MEDICINE

7.5.6 POSITRON EMISSION TOMOGRAPHY

7.5.7 OPTICAL COHERENCE TOMOGRAPHY

7.5.8 ECHOCARDIOGRAPHY

7.5.9 OTHERS

7.6 DERMATOLOGY

7.6.1 ULTRASOUND

7.6.2 X-RAY

7.6.3 MAGNETIC RESONANCE IMAGING

7.6.4 COMPUTED TOMOGRAPHY

7.6.5 OPTICAL COHERENCE TOMOGRAPHY

7.6.6 POSITRON EMISSION TOMOGRAPHY

7.6.7 NUCLEAR MEDICINE

7.6.8 OTHERS

7.7 HEMATOLOGY

7.7.1 ULTRASOUND

7.7.2 COMPUTED TOMOGRAPHY

7.7.3 MAGNETIC RESONANCE IMAGING

7.7.4 X-RAY

7.7.5 POSITRON EMISSION TOMOGRAPHY

7.7.6 NUCLEAR MEDICINE

7.7.7 OPTICAL COHERENCE TOMOGRAPHY

7.7.8 ECHOCARDIOGRAPHY

7.7.9 OTHERS

8 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY MODALITY

8.1 OVERVIEW

8.2 COMPUTED TOMOGRAPHY

8.3 MAGNETIC RESONANCE IMAGING

8.4 ULTRASOUND

8.5 POSITRON EMISSION TOMOGRAPHY

8.6 X-RAY

8.7 ECHOCARDIOGRAPHY

8.8 NUCLEAR MEDICINE

8.9 OPTICAL COHERENCE TOMOGRAPHY

8.10 OTHERS

9 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY END USER

9.1 OVERVIEW

9.2 CONTRACT RESEARCH ORGANIZATION

9.3 MEDICAL DEVICE MANUFACTURERS

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.5 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

10 EUROPE CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 TENDERS SALES

11 EUROPE CLINICAL TRIAL IMAGING MARKET, BY GEOGRAPHY

11.1 EUROPE

11.1.1 GERMANY

11.1.2 FRANCE

11.1.3 U.K.

11.1.4 ITALY

11.1.5 SPAIN

11.1.6 SWITZERLAND

11.1.7 RUSSIA

11.1.8 NETHERLANDS

11.1.9 BELGIUM

11.1.10 TURKEY

11.1.11 REST OF EUROPE

12 EUROPE CLINICAL TRIAL IMAGING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 NAVITAS LIFE SCIENCES

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 SERVICE PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 RESONANCE HEALTH

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 SERVICE PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 BIOTELEMETRY, INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 SERVICEPORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.4 IXICO PLC

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 SERVICE PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.5 ICON PLC

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 SERVICE PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.6 IMAGE CORE LAB

13.6.1 COMPANY SNAPSHOT

13.6.2 SERVICE PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 ANAGRAM 4 CLINICAL TRIALS

13.7.1 COMPANY SNAPSHOT

13.7.2 SERVICE PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 BIOCLINICA

13.8.1 COMPANY SNAPSHOT

13.8.2 SERVICE PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 CARDIOVASCULAR IMAGING TECHNOLOGIES

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.10 ERT CLINICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 SERVICE PORTFOLIO

13.10.3 RECENT DEVELOPMENTS

13.11 INTRINSIC IMAGING

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 SERVICE PORTFOLIO

13.11.4 RECENT DEVELOPMENTS

13.12 LYSCAUT MEDICAL IMAGING COMPANY

13.12.1 COMPANY SNAPSHOT

13.12.2 SERVICE PORTFOLIO

13.12.3 RECENT DEVELOPMENT

13.13 PAREXEL INTERNATIONAL CORPORATION

13.13.1 COMPANY SNAPSHOT

13.13.2 SERVICE PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 PERSPECTUM DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 SERVICE PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 QUOTIENT SCIENCES

13.15.1 COMPANY SNAPSHOT

13.15.2 SERVICE PORTFOLIO

13.15.3 RECENT DEVELOPMENTS

13.16 RADIANT SAGE LLC

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 SERVICE PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 WORLDCARE CLINICAL

13.17.1 COMPANY SNAPSHOT

13.17.2 SERVICE PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 COST OF CLINICAL TRIAL PHASE 2 AND PHASE 3

TABLE 2 HUGE R&D COST IN THE U.S. FOR DIFFERENT PHASES

TABLE 3 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES, 2017-2026 (USD MILLION)

TABLE 4 EUROPE SERVICES IN CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 5 EUROPE SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 6 EUROPE SOFTWARE CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 7 EUROPE CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 8 ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 EUROPE ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 10 EUROPE NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE NEUROLOGYI N CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 EUROPE ENDOCRINOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 14 EUROPE CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 EUROPE CARDIOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 16 EUROPE DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE DERMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 18 EUROPE HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 EUROPE HEMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 21 EUROPE COMPUTED TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 EUROPE MAGNETIC RESONANCE IMAGING IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE ULTRASOUND IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE POSITRON EMISSION TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 EUROPE X-RAY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE ECHOCARDIOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE NUCLEAR MEDICINE IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE OPTICAL COHERENCE TOMOGRAPHYIN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE OTHERS SEGMENTS IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 EUROPE BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE MEDICAL DEVICE MANUFACTURERS COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN CLINICAL TRIAL IMAGINGMARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 EUROPE DIRECT SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 EUROPE TENDERS SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 EUROPE CLINICAL TRIAL IMAGING MARKET,BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 39 EUROPE CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 EUROPE SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 41 EUROPE CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 42 EUROPE CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 EUROPE ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 EUROPE NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 EUROPE ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 46 EUROPE CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 47 EUROPE DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 48 EUROPE HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 49 EUROPE CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 EUROPE CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 51 GERMANY CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION) (USD MILLION)

TABLE 52 GERMANY SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 53 GERMANY CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 54 GERMANY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 GERMANY ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 GERMANY NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 57 GERMANY ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 58 GERMANY CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 GERMANY DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 GERMANY HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 GERMANY CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 GERMANY CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 63 FRANCE CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 FRANCE SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 FRANCE CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 66 FRANCE CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 FRANCE ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 FRANCE NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 FRANCE ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 FRANCE CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 71 FRANCE DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 72 FRANCE HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 FRANCE CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 FRANCE CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 75 U.K. CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 76 U.K. SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 77 U.K. CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 78 U.K. CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 79 U.K. ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 U.K. NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 81 U.K. ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 82 U.K. CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 83 U.K. DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 84 U.K. HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 85 U.K. CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 86 U.K. CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 87 ITALY CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 88 ITALY CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 89 ITALY CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 90 ITALY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 91 ITALY ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 92 ITALY NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 93 ITALY ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 94 ITALY CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 95 ITALY DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 96 ITALY HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 97 ITALY CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 98 ITALY CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 99 SPAIN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 100 SPAIN SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 101 SPAIN CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 102 SPAIN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 103 SPAIN ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 104 SPAIN NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 105 SPAIN ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 106 SPAIN CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 107 SPAIN DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 108 SPAIN HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 109 SPAIN CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 110 SPAIN CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 111 SWITZERLAND CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 112 SWITZERLAND SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 113 SWITZERLAND CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 114 SWITZERLAND CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 115 SWITZERLAND ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 SWITZERLAND NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 117 SWITZERLAND ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 118 SWITZERLAND CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 119 SWITZERLAND DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 120 SWITZERLAND HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 121 SWITZERLAND CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 122 SWITZERLAND CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 123 RUSSIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 124 RUSSIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 125 RUSSIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 126 RUSSIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 127 RUSSIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 128 RUSSIA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 129 RUSSIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 130 RUSSIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 131 RUSSIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 132 RUSSIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 133 RUSSIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 134 RUSSIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 135 NETHERLANDS CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 136 NETHERLANDS SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 137 NETHERLANDS CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 138 NETHERLANDS CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 139 NETHERLANDS ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 140 NETHERLANDS NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 141 NETHERLANDS ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 142 NETHERLANDS CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 143 NETHERLANDS DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 144 NETHERLANDS HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 145 NETHERLANDS CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 146 NETHERLANDS CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 147 BELGIUM CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 148 BELGIUM SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 149 BELGIUM CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 150 BELGIUM CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 151 BELGIUM ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 152 BELGIUM NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 153 BELGIUM ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 154 BELGIUM CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 155 BELGIUM DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 156 BELGIUM HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 157 BELGIUM CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 158 BELGIUM CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 159 TURKEY CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 160 TURKEY SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 161 TURKEY CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 162 TURKEY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 163 TURKEY ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 164 TURKEY NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 165 TURKEY ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 166 TURKEY CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 167 TURKEY DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 168 TURKEY HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 169 TURKEY CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 170 TURKEY CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 171 REST OF EUROPE CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)